William Woods
Stock Analyst at B. Riley Securities
(0.49)
# 4,193
Out of 5,148 analysts
12
Total ratings
23.08%
Success rate
-12.42%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Initiates: Buy | $7 | $1.81 | +286.74% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $435.62 | +53.80% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $1.77 | +182.49% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $1.06 | +183.02% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $2.91 | +243.64% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $6 → $5 | $1.06 | +371.70% | 3 | May 23, 2025 | |
| VERU Veru Inc. | Initiates: Buy | $50 | $2.62 | +1,808.40% | 1 | May 14, 2024 | |
| KRMD KORU Medical Systems | Reiterates: Buy | $4 | $4.87 | -17.86% | 1 | Mar 14, 2024 |
Palisade Bio
Jan 9, 2026
Initiates: Buy
Price Target: $7
Current: $1.81
Upside: +286.74%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $435.62
Upside: +53.80%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $1.77
Upside: +182.49%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $1.06
Upside: +183.02%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.91
Upside: +243.64%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $6 → $5
Current: $1.06
Upside: +371.70%
Veru Inc.
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.62
Upside: +1,808.40%
KORU Medical Systems
Mar 14, 2024
Reiterates: Buy
Price Target: $4
Current: $4.87
Upside: -17.86%